1-(2,3-Dichlorophenyl) Piperazinum Hydrochloridum CAS 119532-26-2 Aripiprazole Puritas Intermedia >99.0% (HPLC) Imago Featured

1-(2,3-Dichlorophenyl) piperazinum Hydrochloridum CAS 119532-26-2 Aripiprazole Puritas media >99.0% (HPLC)

Description:

Nomen: 1-(2,3-Dichlorophenyl) piperazinum hydrochloridum

Synonyma: 2,3-DCPP HCl

CAS: 119532-26-2

Puritas: >99.0% (HPLC)

Aspectus: Alba vel Off-White pulveris

Medium Aripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple intermedia Aripiprazole Cum High puritate
Aripiprazole API CAS 129722-12-9
1-(2,3-Dichlorophenyl) piperazinum hydrochloridum CAS 119532-26-2
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0
7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone CAS 129722-34-5

Chemical Properties:

Nomen chemicum	1-(2,3-Dichlorophenyl) piperazinum hydrochloridum
Synonyma	2,3-DCPP HCl;1-(2,3-Dichlorophenyl) piperazinum HCl;Aripiprazole EP Impuritas B;Aripiprazole Related Compone C
CAS Number	119532-26-2
CATTUS Number	RF-PI2268
Stock Status	In Stock, Productio Capacity 30 MT/Month
Formulae hypotheticae	C10H12Cl2N2·HCl
M. Pondus	267.58
Liquescens punctum	245.0~247.0℃
Repono & Sensibilitas	Hygroscopic.ambientium temperaturis
Solubilitas in aqua	Solutum in aqua
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba vel Off-White pulveris
Puritas / Analysis Methodus	>99.0% (HPLC)
Damnum in Siccatio	<0.50%
Residere in Ignition	<0.10%
una immunditia	<0.50%
Totalis immunditias	<1.00%
Metalla gravia (ut Pb)	≤20ppm
Infrared Imaginis	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Medium Aripiprazole (CAS: 129722-12-9)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Hygroscopic.Reponunt ab aqua/umido et oxidizing agentium.Continens arcte clausam et pone in conditione frigido, sicco et bene ventilato.Reponunt sub inertem gas

commoda:

FAQ:

Applicatio:

1-(2,3-Dichlorophenyl) piperazinum hydrochloridum (CAS: 119532-26-2) intermedium magni ponderis est Aripiprazole (CAS: 129722-12-9).Aripiprazole novum genus derivatorum quinolineorum solubilium valde lipidorum, effectus pharmacologicus proprius est quod non solum dopamine postsynapticum D 2 receptor antagonista, sed etiam dopamine presynaptico D 2 receptor agonist, potest etiam excitare D 1, D 3, D 4 receptores ;effectum dualem habet activationis partialis seu receptoris contra 5-HT 1A receptoris;actionem omnino contrariam in receptore 5-HT 2A habet.Hoc pluma differt a generatione prima et antipsychoticis atypicis quae pertinent ad medicinae secundae generationem antipsychoticam, et ideo ratio dopamine stabilitrix vel tertia generatio antipsychotica appellatur.Cum in foro venditur, maxime adhibetur in schizophrenia clinica, curatione perturbationum affectivarum aliarumque psychiatricarum perturbationum.Secundum litterae, aripiprazole significantes effectus in schizophrenia affirmativa et negativa signa et anxietatem, tristitia, munus cognoscitivum habet, cum superiore salute.Dictum etiam est medicamentum etiam alias perturbationes mentis tractare, sicut perturbationes modi episodium manicum, dementiam senilem cum perturbationibus mentis coniungi, perturbationes anxietas, perturbationes disordines morum filiorum, tristitia.Hodie, Bristol-Myers Squibb et Otsuka Pharmaceutical Societas nuntiavit Unionem Europaeam approbasse Abiliprazole (aripiprazole) in applicatione schizophreniae tractandae.